FORM 4

[__] Check this box if no longer
subject to Section 16. Form 4 or Form
5 obligations may continue.
See Instruction 1(b).

(Print or Type Responses)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL



OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden
hours per response. . . . . 0.5
1. Name and Address of Reporting Person*
   Ando, Goran 

(Last)                      (First)                      (Middle)

  100 Route 206 North

(Street)

  Peapack, NJ 07977

(City)                      (State)                      (Zip)

2. Issuer Name and Ticker
    or Trading Symbol

   Pharmacia Corporation - PHA

3. I.R.S. Identification
    Number of Reporting
    Person, if an entity
    (voluntary)

     
4. Statement for
    (Month/Day/Year)

   11/05/02


5. If Amendment,
    Date of Original
    (Month/Day/Year)

    
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)


  __   Director                                __   10% Owner

   X    Officer (give title below)        __   Other (specify below)

    Executive Vice President    

7. Individual or Joint/Group Filing (Check Applicable Line)

  _ X    Form filed by One Reporting Person

  ____    Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security
    (Instr. 3)

2. Transaction Date
    (Month/Day/Year)
2A. Deemed Execution       Date, if any
      (Month/Day/Year)
3. Transaction Code
    (Instr. 8)
4. Securities Acquired (A) or
    Disposed of (D)
    (Instr. 3, 4, and 5)
5. Amount of
    Securities
    Beneficially
    Owned
    Following     Reported     Transaction(s)
    (Instr. 3 and 4)
6. Ownership Form:
    Direct (D) or
    Indirect (I)
    (Instr. 4)
7. Nature of Indirect Beneficial
    Ownership
    (Instr. 4)
Code V Amount (A) or (D) Price Common11/05/2002 S 10,000D$44.3014,235D Common       7,822ISavings Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
    (Instr. 3)
2. Conver-
    sion or
    Exercise
    Price of
    Deri-
    vative
    Security
3. Transaction
    Date  (Month/
    Day/ Year)
3A. Deemed
      Execution Date,
      if any (Month/
      Day/ Year)
4. Transaction Code     
    (Instr.8)

5. Number of
   
Derivative
    Securities Acquired
    (A)
    or Disposed of (D)
    (Instr. 3, 4 and 5)

6. Date Exercisable and
    Expiration Date
    (Month/Day/Year)
7. Title and Amount
    of  Underlying
    Securities
    (Instr. 3 and 4)
8. Price of
    Derivative
    Security
    (Instr. 5)
9. Number of
    Derivative
    Securities
    Beneficially
    Owned
    Following
    Reported
    Transaction(s)
    (Instr. 4)
10. Ownership
     Form of      Derivative
     Securities:
     Direct (D)
     or
     Indirect (I)
     (Instr. 4)
11. Nature of
      Indirect
      Beneficial
      Ownership
      (Instr. 4)
Code V (A) (D) Date
Exercisable
Expiration
Date
Title Amount or
Number of
Shares
Option (right to buy)$39.2701/04/2002 AV208,537  (1) 01/04/2012Common208,537 208,537D Option (right to buy)$39.2701/04/2002 AV2,546 01/04/200501/04/2012Common2,546 2,546D 

Explanation of Responses:  (1) One-third of the shares granted become exercisable on each of the first, second and third anniversary of the grant date.

            /s/ Don W. Schmitz, attorney-in-fact for Goran Ando                     11/06/2002    ** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
        See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:   File three copies of this Form, one of which must be manually signed. If space is insufficient,
            See Instruction 6 for procedure.